Myriad Genetics, Inc. (MYGN) P/S ratio

P/S ratio today
0.6×

Myriad Genetics, Inc. (MYGN) trades at 0.6× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 0.7×. That is 53.4% lower than the 1.5× of fiscal 2024. Figures as of 18 Nov 2026, 10:31 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/S ratio today
0.6×
P/S ratio, fiscal 2025
0.7×
Change on fiscal 2024
−53.4%
Highest on record
10.8×fiscal 2009
Lowest on record
0.7×fiscal 2025
Fiscal years on record
182009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Myriad Genetics, Inc. P/S ratio, in more detail

Today's figure is 9.9% below the fiscal 2025 year-end.

Across the 18 fiscal year-ends on record (2009–2025), the highest was 10.8× in fiscal 2009 and the lowest 0.7× in fiscal 2025. Today's P/S ratio is at or below every one of the 18 fiscal year-ends on record; their median is 3.1×.

History · 18 fiscal years

P/S ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Myriad Genetics, Inc. P/S ratio, year by year

Myriad Genetics, Inc. (MYGN) P/S ratio by fiscal year
Fiscal yearP/S ratioChangeYear endedShare price at year-endRevenue per share
Today0.6×—$5.54—
20250.7× 53.4% down$6.15$8.90
20241.5× 29.5% down$13.71$9.25
20232.1× 22.1% up$19.14$9.10
20221.7× 44.7% down$14.51$8.42
20213.1× 17.4% up$27.60$8.85
20202.7×—$19.77$7.45
20201.3× 46.8% down$11.34$8.59
20192.5× 31.4% down$27.78$11.20
20183.6× 48.3% up$37.37$10.33
20172.4× 19.6% down$25.84$10.59
20163.0× 13.5% down$30.60$10.09
20153.5× 10.4% down$33.99$9.70
20143.9× 7.1% up$38.92$9.95
20133.7× 11.9% down$26.87$7.36
20124.1× 20.0% down$23.77$5.74
20115.2× 26.7% up$22.71$4.38
20104.1× 62.0% down$14.95$3.66
200910.8×—$35.65$3.31

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

More on MYGN

Myriad Genetics, Inc., figure by figure

Myriad Genetics, Inc. (MYGN) overview: price, valuation and scorecard

Myriad Genetics, Inc. P/S ratio: questions and answers

What is Myriad Genetics, Inc.'s P/S ratio?

Myriad Genetics, Inc. (MYGN) trades at 0.6× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 0.7×. That is 53.4% lower than the 1.5× of fiscal 2024.

Is Myriad Genetics, Inc.'s P/S ratio high or low compared with its own history?

Today's P/S ratio is at or below every one of the 18 fiscal year-ends on record; their median is 3.1×.

What are the highest and lowest P/S ratio figures on record for Myriad Genetics, Inc.?

Across the 18 fiscal year-ends on record (2009–2025), the highest was 10.8× in fiscal 2009 and the lowest 0.7× in fiscal 2025.

How is Myriad Genetics, Inc.'s P/S ratio calculated?

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end. For Myriad Genetics, Inc. it is on record here for 18 fiscal years, 2009 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Myriad Genetics, Inc. (MYGN) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/MYGN/ps-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.